Stock market today: Wall Street ticks higher ahead of the Fed’s decision on interest rates
U.S. stocks are ticking higher ahead of the Federal Reserve’s announcement coming later in the afternoon about what it will ...
McKesson upgraded at Baird on Core Ventures deal after Q2 beat
Baird upgraded McKesson (NYSE:MCK) to outperform from neutral on Thursday, citing the updates the medical distributor gave ...
Stock market today: Wall Street is mixed as its momentum slows ahead of the Fed's decision
U.S. stocks are ticking higher Thursday, ahead of the Federal Reserve’s announcement coming in the afternoon about what it ...
McKesson's Fiscal Q2 EPS Tops Forecast
McKesson's earnings for its fiscal 2025 second quarter exceeded expectations, despite special charges that cut into net ...
McKesson: Strong Q2 Performance and Raised FY 2025 Guidance Justify Buy Rating
McKesson (MCK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz ...
McKesson’s Strong Q2 Performance Leads to Upward EPS Revision, But Hold Rating Due to Segment Concerns and Uncertain Long-Term Growth
Steve Baxter, an analyst from Wells Fargo, maintained the Hold rating on McKesson (MCK – Research Report). The associated price target ...
MarketWatch3h
McKesson Shares Jump After FY25 Outlook Boost, Strong 2Q Sales
Shares of McKesson climbed after the drug distributor raised its fiscal-year guidance and reported strong sales growth during its fiscal second quarter. The stock was up 11%, at $610.99, in midday ...
McKesson Corp (MCK) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
McKesson Corp (MCK) reports a 21% revenue increase and raises fiscal 2025 EPS guidance amid strategic expansions and ...
Stock market today: Most of Wall Street rises after the Fed cuts interest rates
Most U.S. stocks rose Thursday, as the Federal Reserve cut interest rates again to make things easier for the economy. The ...
MarketWatch3m
McKesson Corp. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
These Analysts Boost Their Forecasts On McKesson Following Upbeat Earnings
McKesson MCK reported better-than-expected second-quarter financial results on Wednesday. McKesson reported quarterly earnings of $7.07 per share which beat the analyst consensus estimate of $6.88 per ...
What you need to know in Baltimore’s opioid case before it heads to jurors
Fletcher-Hill sends the case to the jury for consideration. Baltimore alleges that the companies, McKesson and AmerisourceBergen, flooded the city with hundreds of millions of addictive pain pills ...